| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |